Zenith Capital (TSXV:ZENI.P) Momentum Rank : 4 (As of May. 29, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Zenith Capital Momentum Rank?

Zenith Capital has the Momentum Rank of 4.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Zenith Capital's Momentum Rank

For the Biotechnology subindustry, Zenith Capital's Momentum Rank, along with its competitors' market caps and Momentum Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zenith Capital's Momentum Rank Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zenith Capital's Momentum Rank distribution charts can be found below:

* The bar in red indicates where Zenith Capital's Momentum Rank falls into.

Zenith Capital Momentum Rank Related Terms

Thank you for viewing the detailed overview of Zenith Capital's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Zenith Capital (TSXV:ZENI.P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenith Capital Corporation (TSXV:ZENI.P) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

2475 Queens Avenue, West Vancouver, BC, CAN, V7V 2Y9

Website

https://www.zenithepigenetics.com

Zenith Capital Corporation is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics for the treatment of cancer and other disorders with significant unmet medical needs. The company is developing various novel combinations of BET inhibitors with other targeted agents. The lead compound, ZEN-3694, is in clinical development for mCRPC in combination with androgen receptor inhibitor, XTANDI, with Astellas and Newsoara as collaborators; triple-negative breast cancer in combination with the PARP inhibitor TALZENNA with Pfizer as a collaborator; androgen receptor independent mCRPC in combination with immune checkpoint inhibitor KEYTRUDA and XTANDI with University of California, San Francisco as a collaborator.

Zenith Capital (TSXV:ZENI.P) Headlines

No Headlines